Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
49.49 x 2 61.00 x 2
Post-market by (Cboe BZX)
57.11 -1.21 (-2.07%) 03/26/25 [NASDAQ]
49.49 x 2 61.00 x 2
Post-market 56.65 -0.46 (-0.81%) 16:01 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
56.52
Day High
58.76
Open 58.26
Previous Close 58.32 58.32
Volume 636,400 636,400
Avg Vol 1,208,355 1,208,355
Stochastic %K 67.71% 67.71%
Weighted Alpha +100.66 +100.66
5-Day Change -0.89 (-1.53%) -0.89 (-1.53%)
52-Week Range 20.84 - 75.00 20.84 - 75.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,152,935
  • Shares Outstanding, K 105,503
  • Annual Sales, $ 675,040 K
  • Annual Income, $ 141,210 K
  • EBIT $ 137 M
  • EBITDA $ 127 M
  • 60-Month Beta 0.61
  • Price/Sales 9.29
  • Price/Cash Flow 47.88
  • Price/Book 9.17

Options Overview Details

View History
  • Implied Volatility 78.04% ( -0.85%)
  • Historical Volatility 52.34%
  • IV Percentile 63%
  • IV Rank 44.90%
  • IV High 156.92% on 05/17/24
  • IV Low 13.78% on 08/16/24
  • Put/Call Vol Ratio 0.79
  • Today's Volume 1,398
  • Volume Avg (30-Day) 2,575
  • Put/Call OI Ratio 1.69
  • Today's Open Interest 39,143
  • Open Int (30-Day) 46,202

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.17
  • Number of Estimates 4
  • High Estimate 0.18
  • Low Estimate 0.16
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -32.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.45 +8.88%
on 03/07/25
Period Open: 63.37
64.66 -11.68%
on 02/27/25
-6.26 (-9.88%)
since 02/26/25
3-Month
49.00 +16.55%
on 01/13/25
Period Open: 53.63
75.00 -23.85%
on 02/19/25
+3.48 (+6.49%)
since 12/26/24
52-Week
20.84 +174.04%
on 04/22/24
Period Open: 24.75
75.00 -23.85%
on 02/19/25
+32.36 (+130.75%)
since 03/26/24

Most Recent Stories

More News
3 Reasons to Sell CORT and 1 Stock to Buy Instead

3 Reasons to Sell CORT and 1 Stock to Buy Instead

CORT : 57.11 (-2.07%)
TDG : 1,394.04 (-0.01%)
3 Growth Stocks in Hot Water

3 Growth Stocks in Hot Water

CORT : 57.11 (-2.07%)
NX : 19.71 (-0.30%)
SEM : 16.96 (-0.64%)
1 Small-Cap Stock on Our Buy List and 2 to Avoid

1 Small-Cap Stock on Our Buy List and 2 to Avoid

CORT : 57.11 (-2.07%)
SEMR : 9.86 (-0.70%)
NYT : 49.33 (+0.39%)
Corcept Shares Rise More Than 55% in 6 Months: Here's Why

Shares of Corcept Therapeutics Incorporated CORT have rallied 56.4% in the past six months against the industry’s decline of 10.5%.The company’s sole-marketed drug, Korlym (mifepristone), which is...

CORT : 57.11 (-2.07%)
JAZZ : 130.88 (-3.23%)
ANIP : 67.17 (+1.27%)
ORGO : 4.70 (-10.06%)
Are Options Traders Betting on a Big Move in Corcept Therapeutics (CORT) Stock?

Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $20 Call had some of the highest...

CORT : 57.11 (-2.07%)
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

CORT : 57.11 (-2.07%)
RPRX : 31.56 (-6.52%)
SUPN : 32.33 (-2.18%)
OGN : 14.71 (-0.07%)
ZTS : 162.82 (+0.94%)
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

CORT : 57.11 (-2.07%)
SUPN : 32.33 (-2.18%)
MRK : 88.11 (+0.27%)
ZTS : 162.82 (+0.94%)
BMY : 59.21 (+0.03%)
Why Corcept (CORT) Shares Are Sliding Today

Why Corcept (CORT) Shares Are Sliding Today

CORT : 57.11 (-2.07%)
Corcept: Q4 Earnings Snapshot

Corcept: Q4 Earnings Snapshot

CORT : 57.11 (-2.07%)
Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q4 Earnings

Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q4 Earnings

CORT : 57.11 (-2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 60.65
2nd Resistance Point 59.70
1st Resistance Point 58.41
Last Price 57.11
1st Support Level 56.17
2nd Support Level 55.22
3rd Support Level 53.93

See More

52-Week High 75.00
Last Price 57.11
Fibonacci 61.8% 54.31
Fibonacci 50% 47.92
Fibonacci 38.2% 41.53
52-Week Low 20.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies